Response to: Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18(2):239-47, 2019, DOI: 10.1002/pst.1920.

Jin, Kun; Dunn, Billy

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Response to: Counterpoint to Jin et al, On weighted composite scores for early Alzheimer's trials. Pharm Stat. 18(2):239-47, 2019, DOI: 10.1002/pst.1920.

Jin, Kun; Dunn, Billy.

Affiliation

Jin K; Division of Biometrics I, CDER, FDA, USA.
Dunn B; Office of Neuroscience, CDER, FDA, USA.

Pharm Stat ; 19(4): 494, 2020 07.

Article in En | MEDLINE | ID: mdl-32147934

Subject(s)

Fulltext

Add to My VHL

Print

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Limits: Humans Language: En Journal: Pharm Stat Journal subject: FARMACOLOGIA Year: 2020 Document type: Article Affiliation country: Country of publication: